Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1021532.RAABqpVnrY4uShKkDkUzWg496NnF7TUXMSzcXa5-84Le0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1021532.RAABqpVnrY4uShKkDkUzWg496NnF7TUXMSzcXa5-84Le0130_assertion type Assertion NP1021532.RAABqpVnrY4uShKkDkUzWg496NnF7TUXMSzcXa5-84Le0130_head.
- NP1021532.RAABqpVnrY4uShKkDkUzWg496NnF7TUXMSzcXa5-84Le0130_assertion description "[2-phenylimidazo[2,1-b]benzothiazole derivatives have been highlighted for their properties of targeting oncogenic Met receptor tyrosine kinase (RTK) signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1021532.RAABqpVnrY4uShKkDkUzWg496NnF7TUXMSzcXa5-84Le0130_provenance.
- NP1021532.RAABqpVnrY4uShKkDkUzWg496NnF7TUXMSzcXa5-84Le0130_assertion evidence source_evidence_literature NP1021532.RAABqpVnrY4uShKkDkUzWg496NnF7TUXMSzcXa5-84Le0130_provenance.
- NP1021532.RAABqpVnrY4uShKkDkUzWg496NnF7TUXMSzcXa5-84Le0130_assertion SIO_000772 23071625 NP1021532.RAABqpVnrY4uShKkDkUzWg496NnF7TUXMSzcXa5-84Le0130_provenance.
- NP1021532.RAABqpVnrY4uShKkDkUzWg496NnF7TUXMSzcXa5-84Le0130_assertion wasDerivedFrom befree-2016 NP1021532.RAABqpVnrY4uShKkDkUzWg496NnF7TUXMSzcXa5-84Le0130_provenance.
- NP1021532.RAABqpVnrY4uShKkDkUzWg496NnF7TUXMSzcXa5-84Le0130_assertion wasGeneratedBy ECO_0000203 NP1021532.RAABqpVnrY4uShKkDkUzWg496NnF7TUXMSzcXa5-84Le0130_provenance.